Perampanel Study

Mount Sinai School of Medicine is conducting an essential tremor research trail. This study is only open to those living in the New York City area. This research trial will study persons who:

  • have essential tremor
  • have troublesome hand tremor
  • have tremor in both hands
  • do not have liver insufficiency

The purpose of this research study is to find out whether perampanel, a medication marketed for the treatment of seizures, reduces hand tremor in persons with essential tremor. Participants will have tremor observed and video-taped and answer questionnaires so that investigators can find out whether perampanel reduces tremor. During the study, perampanel is taken for 14 weeks, and placebo for 14 weeks. Total participation will last up to 40 weeks. There are a total of 6 visits, and participants will be compensated on each visit.

To learn more about “A Double-Blind, Cross-Over, Placebo-Controlled Efficacy and Tolerability Study of Perampanel for Essential Tremor” contact the Principal Investigator:

Mindy Lopez
The Robert and John M. Benheim Parkinson’s and Movement Disorders Center
New York, NY
212-241-9038
mindy.lopez1@mssm.edu

Winona Tse, MD
Department of Neurology
Icahn School of Medicine at Mount Sinai
5 East 98th St., New York
212-241-5607
winona.tse@mssm.edu

Joan Bratton
212-241-0279 or joan.bratton@mssm.edu